Ruthigen Inc (NASDAQ:RTGN)

3.77
Delayed Data
As of Mar 26
 +0.1399 / +3.85%
Today’s Change
3.31
Today|||52-Week Range
7.24
+7.71%
Year-to-Date

Today’s Trading

Previous close3.63
Today’s open3.65
Day’s range-- - --
Volume6,424
Average volume (3 months)12,173
Market cap$17.4M
Dividend yield--
Data as of 03/26/2015

Growth & Valuation

Earnings growth (last year)-488.46%
Earnings growth (this year)+8.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
OPXAOpexa Therapeutics I...-0.00-0.45%
RGDXResponse Genetics In...+0.03+6.73%
BSPMBiostar Pharmaceutic...+0.03+2.52%
KBIOKaloBios Pharmaceuti...-0.03-4.95%
Data as of 03/26/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$3.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Science Officer
Hojabr Alimi
Chief Financial Officer
Sameer Harish
Corporate headquarters
Santa Rosa, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account